about
Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variantsPrimary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variantsC-reactive protein: a critical updateUsing GWAS to identify genetic predisposition in hepatic autoimmunityThe gut microbiota and host health: a new clinical frontierRisk stratification in autoimmune cholestatic liver diseases: Opportunities for clinicians and trialistsThe immunogenetics of primary biliary cirrhosis: A comprehensive reviewThe Immunogenetics of Autoimmune CholestasisGenome-wide meta-analyses identify three loci associated with primary biliary cirrhosisDense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis.Transgenic human C-reactive protein is not proatherogenic in apolipoprotein E-deficient mice.Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: a multicentre international study.Portal hypertension in polycystic liver disease patients does not affect wait-list or immediate post-liver transplantation outcomes.Low-dose interleukin-2 promotes STAT-5 phosphorylation, Treg survival and CTLA-4-dependent function in autoimmune liver diseasesAutoantibodies and liver disease: uses and abuses.Targeting C-reactive protein for the treatment of cardiovascular disease.Carriage of a tumor necrosis factor polymorphism amplifies the cytotoxic T-lymphocyte antigen 4 attributed risk of primary biliary cirrhosis: evidence for a gene-gene interaction.Variants at IRF5-TNPO3, 17q12-21 and MMEL1 are associated with primary biliary cirrhosisGenome-wide association study identifies loci influencing concentrations of liver enzymes in plasma.C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease.Treatment of autoimmune liver disease: current and future therapeutic options.Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid.PR3-ANCA: a promising biomarker in primary sclerosing cholangitis (PSC).Transgenic human CRP is not pro-atherogenic, pro-atherothrombotic or pro-inflammatory in apoE-/- mice.The IRF5-TNPO3 association with systemic lupus erythematosus has two components that other autoimmune disorders variably shareFatal reactivation of hepatitis B after chemotherapy for lymphoma.Anti-kelch-like 12 and anti-hexokinase 1: novel autoantibodies in primary biliary cirrhosis.IgG4 related disease - a retrospective descriptive study highlighting Canadian experiences in diagnosis and management.Frequency and significance of IgG4 immunohistochemical staining in liver explants from patients with primary sclerosing cholangitis.Amyloidosis: new strategies for treatment.A comprehensive assessment of environmental exposures among 1000 North American patients with primary sclerosing cholangitis, with and without inflammatory bowel disease.Amyloidosis: a clinico-pathophysiological synopsis.Characterization of animal models for primary sclerosing cholangitis (PSC).Association of primary biliary cirrhosis with variants in the CLEC16A, SOCS1, SPIB and SIAE immunomodulatory genes.BAT117213: Ileal bile acid transporter (IBAT) inhibition as a treatment for pruritus in primary biliary cirrhosis: study protocol for a randomised controlled trialInternational genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways.Intestinal CCL25 expression is increased in colitis and correlates with inflammatory activity.Single-gene association between GATA-2 and autoimmune hepatitis: A novel genetic insight highlighting immunologic pathways to disease.Klinefelter's syndrome (47,XXY) is in excess among men with Sjögren's syndromeLoss of CD28 expression by liver-infiltrating T cells contributes to pathogenesis of primary sclerosing cholangitis
P50
Q24617796-3796F5C0-DF7E-4184-881F-EABDB9FD1B30Q24633806-AB869A03-FAEF-448E-97B5-A940EE8EE892Q24672855-40590D7F-531C-4BED-BD89-D2BB33A6EC0FQ26782991-0F4C4241-1406-4A13-9832-11CCA08B1691Q26785649-67CF83AF-1025-4260-A41F-C9413108C000Q26796355-8F764738-4CFB-4A3B-A001-A99D25463421Q26801377-2A2C766B-FC64-409E-8871-B79DC47F6CDDQ28085346-B67409FF-FB6B-489C-A518-B5E5BE850367Q28943317-D10EF8CC-C317-4B3C-ACC1-B331447ED8D1Q30416155-C39FD3DB-BCB9-4B5F-9FBB-2EDFE86C27F0Q30475959-8007D2C9-F6FD-472B-8B77-490029044331Q33419647-2338D678-961F-4970-8255-A2793B218B1DQ33437890-9B9D5E92-E485-4B05-985B-0518978654C6Q33650813-145C31E6-D506-4775-A2A4-DE525422D574Q33829963-06CE7D2D-2504-4C62-B4A4-D31BEE317AEFQ33995386-1A647CA8-521D-463F-8B76-CF3949C1F1C3Q34070579-9C344260-C826-47EE-81BE-17FC42CFE236Q34087671-3C49276A-3C6F-4918-B15D-972FB6383A04Q34224637-1D73EAF9-ACE0-4E07-89EC-32DCA7C02F67Q34311841-A3ABCBFD-5243-44A2-BCE2-60ABDF977071Q34342199-A5B72C70-D297-41CB-AC0D-530D19D61C55Q34453425-B299D9EC-4D4D-4E74-B87C-F9622498BA27Q34514665-32811C60-37C6-418F-816E-F985307A825EQ34641225-11BC70C0-C60A-4C3B-943A-31318CE3A017Q34764041-62FBB487-31FF-473A-A717-B664D6EB01BFQ34791395-35A92C27-11C4-4DE2-A094-91B63BA23599Q35008069-A24B2987-01D3-444C-B6AA-DF675FFC7D8CQ35062828-A507F34A-0628-4486-BCED-1F0C5E8EB64FQ35154201-1D12D184-F4EF-40BC-A6EF-61B0A127143DQ35214659-A99FE527-7B0D-4557-929B-5968C9B35EFBQ35470575-4A179B15-F22C-4715-9C99-BFF437883A62Q35703306-5EB06D99-D311-4E11-B9E0-755F2E47DFAFQ35896870-9DCBF72B-7F69-4B16-8C37-BD655889272EQ35990216-B973122D-D8FA-40B3-AD61-5302238CE532Q36080972-6F258FBC-69E9-4483-889D-B4308FB9D1A0Q36087896-B7CE20E7-AB51-439D-8A36-2AE89AEA3FB1Q36715515-7C97D4E6-3414-4652-8ED0-6C6575EEA311Q36777826-737202BC-D07A-4CEE-BC6B-70059A38F5D1Q37083442-6A3515E8-508F-4D0A-8FBB-E0A8D35D2ACCQ37127058-8AF38AA8-0078-4027-88FB-FD5C582C0BE3
P50
description
gastroenteroloog
@nl
scientist
@en
name
Gideon M Hirschfield
@nl
Gideon M Hirschfield
@sl
Gideon M. Hirschfield
@en
Gideon M. Hirschfield
@es
type
label
Gideon M Hirschfield
@nl
Gideon M Hirschfield
@sl
Gideon M. Hirschfield
@en
Gideon M. Hirschfield
@es
altLabel
Gideon Hirschfield
@en
Gideon M Hirschfield
@en
prefLabel
Gideon M Hirschfield
@nl
Gideon M Hirschfield
@sl
Gideon M. Hirschfield
@en
Gideon M. Hirschfield
@es
P214
P227
P244
P1053
M-2143-2015
P1153
6602933572
P21
P213
0000 0003 6808 2885
P214
P227
101801389X
P244
nb2012000107
P2798
P31
P3829
P496
0000-0002-6736-2255
P7859
lccn-nb2012000107